Frazier Life Sciences Management, L.P.

Frazier Life Sciences Management, L.P., led by co-founders and biotech veterans John Frazier and John Higgins, maintains a concentrated portfolio with a focus on early-stage biotech companies, currently managing $3.7 billion in assets across 40 positions. Notably, the fund has recently added RAPT, VOR, and MNKD, while exiting VRNA and RARE, and significantly increased positions in ACAD and RNAM, reflecting its strategy of capitalizing on high-growth potential in the biotech sector.

📌 Top Holdings